CION Ameerpet
If you are on dialysis or living with chronic kidney disease, you have probably been told your kidney cancer risk is higher than average. That is true — but it is worth knowing what the risk actually is before it keeps you awake. Kidneys damaged by years of kidney failure commonly fill with small cysts, and the great majority of those cysts are entirely harmless. Up to a third of small kidney masses turn out to be benign, and where a cancer is found in a kidney like this, it is usually small, early and picked up on a scan long before it causes any symptom. This page explains the mechanism, which cyst features matter, and when a scan is worth arranging. For the wider picture, start with our complete kidney cancer guide.
No. The honest position is that the risk is higher than it is for someone with two healthy kidneys, and that it climbs the longer kidney failure has been present — and that even so, most people on dialysis never develop kidney cancer. Both halves of that sentence are true, and the second half is the one that usually gets left out of the conversation.
It is also worth separating a cyst from a cancer, because on a scan report they can sit uncomfortably close together. Up to a third of small kidney masses are benign, and simple cysts — thin-walled, filled with clear fluid, taking up no contrast — are among the commonest things any radiologist sees. In a kidney that has been failing for years, finding several of them is expected rather than alarming. Where a kidney cancer is found in this setting, it is usually small, often confined to the kidney, and detected on imaging before it has produced a single symptom — which is the version of this diagnosis that is most treatable.
What changes the picture is not how many cysts there are but how one of them looks. A thickened or irregular wall, partitions running through the fluid, or a solid area that lights up with contrast are the features that make a radiologist look twice. Those features, and what is done about them, are set out further down this page. If you want the full list of what raises kidney cancer risk in general — smoking, weight, blood pressure, family history and more — that is covered on what raises your risk of kidney cancer, and the wider picture — symptoms, how a diagnosis is made and what treatment involves — sits on our complete guide to kidney cancer.
A raised risk means kidney cancer is looked for more carefully in people with long-standing kidney failure. It does not mean it is expected, and most people on dialysis never develop it.
It is the number of years the kidneys have been failing that drives the change, not the dialysis machine. The same cysts can appear in advanced kidney disease before dialysis ever starts.
Simple cysts need nothing more than a note in the report. Only a lesion with solid or enhancing features moves from being an observation to being a question.
Because these kidneys are scanned more often than most, a cancer arising in one is frequently picked up while it is still small and confined — before any symptom appears.
Acquired cystic kidney disease and the inherited kind are frequently confused, and they are not the same thing at all. Acquired cysts develop in kidneys that have been damaged by long-standing kidney disease: the kidneys stay small, or shrink further, and slowly become studded with small fluid-filled spaces. Nobody is born with them and they are not passed on to children. The inherited condition works the other way round — it is present from birth, it runs in families, and the kidneys enlarge, sometimes dramatically, over decades. The two carry different implications for your relatives and for how you are followed up, which is why it is worth knowing which one a report is describing. The inherited form is covered separately on our page about polycystic kidney disease and cancer risk.
None of these means you have cancer. Each is a reason for your kidney team to keep the native kidneys in view rather than assume nothing is happening in them.
Acquired cysts become more common the longer the kidneys have been failing, and the chance of a tumour arising within them follows the same curve. Duration is the single strongest factor here.
Someone who begins dialysis in their twenties or thirties has far more years of exposure ahead of them than someone who starts in later life, which is why age at the start is asked about.
The original kidneys are usually left in place at transplant. Their cysts do not disappear the day the new kidney starts working, and long-term immunosuppression is a factor of its own.
In anyone who still passes urine, even a single painless episode is always worth checking promptly — although infection, stones and the kidney disease itself explain most of it, not cancer.
A dull ache fixed over one side, or a lump you can feel in the flank, is worth an examination and a scan rather than being put down to dialysis or a long-standing back problem.
Anaemia is expected in kidney failure, because damaged kidneys make less erythropoietin. A haemoglobin that unexpectedly rises, or support needs that fall without explanation, is worth mentioning.
Smoking raises kidney cancer risk on its own, and it sits on top of whatever the kidney disease contributes. Stopping is the single most useful thing anyone in this group can do.
Weight coming off without trying, or a persistent low-grade fever with no infection found, deserves a look at the kidneys as part of a wider assessment.
Heavy visible bleeding, sudden severe flank pain, or feeling acutely unwell with a high fever needs same-day assessment — go to your dialysis unit or the nearest emergency department rather than waiting for an appointment.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
CION Ameerpet
CION Kukatpally
CION L.B. Nagar
CION Tolichowki
CION Masab Tank
CION Banjara Hills
CION Kompally
CION Balanagar
CION Siddipet
CION Sangareddy
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centreTravelling for treatment? We may have a centre right where you are.
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
Care is led by medical and radiation oncology, coordinating a wider uro-oncology team — part of 17 senior specialists across CION, with 150+ years of combined experience.
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationShare your name and number — we'll call you back within 30 minutes to schedule your consultation.
No referral needed and no cost for the first consultation. Most people leave with a reassuring answer — and it is still better to have been told than to have wondered.
There is no national programme that scans everybody on dialysis, and scanning everyone routinely has not turned out to be the right answer for every patient. What follows is how the decision is usually reached, and what happens once a scan has been done.
How long the kidneys have been failing, how long you have been on dialysis, what age you started, whether a transplant is planned, whether you still pass urine, and whether anything has changed. Smoking history, weight and blood pressure belong here too. Most of the decision about whether to image is made in this conversation rather than by any rule.
An ultrasound of the native kidneys is the sensible first look: painless, radiation-free, no contrast and widely available. It shows the size of the kidneys, how many cysts there are, and whether any of them has a wall or an internal component that does not look simple. For a great many people this is where the assessment stops.
Small shrunken kidneys packed with cysts are genuinely harder to read than healthy ones, so a cross-sectional scan is often needed to settle a question. Whether contrast can be given, and which kind, depends on your remaining kidney function, whether you are already on dialysis and how your sessions are scheduled. That is a joint decision between the oncology team, the radiologist and your nephrologist — never one taken in isolation.
Cystic lesions in the kidney are described using the Bosniak system, which sorts them by wall thickness, internal partitions, calcification and, most importantly, whether any solid part takes up contrast. The category is what determines whether a lesion is ignored, watched or acted on, and it is why the wording of a radiology report matters more than the size in millimetres.
An indeterminate lesion is frequently followed with repeat imaging at intervals rather than investigated immediately. Stability over time is genuinely reassuring; growth or a new enhancing component is what changes the plan. Interval imaging is an active decision, not a way of avoiding one, and it is monitoring CION delivers in-house.
Where imaging is not conclusive, an image-guided biopsy can settle what a lesion is. Nothing is decided by one clinician working alone: scans, bloods and any biopsy go to a tumour board, and NCCN guidance frames how a small renal mass is categorised and managed. What each option involves is set out on our kidney cancer treatment in Hyderabad page, and you can book a consultation to talk it through first.
A plain-language guide to the Bosniak categories your radiology report may use. This is a description of how lesions are sorted, not a diagnosis: only the team holding your scans can say which row you are in.
| Category | What the scan shows | What usually happens |
|---|---|---|
| Bosniak I | A simple cyst — hairline-thin wall, clear fluid, no partitions, no calcium, no enhancement. | Considered benign. No follow-up imaging is needed for the cyst itself. |
| Bosniak II | A few hairline partitions, or fine calcification, with no measurable enhancement. | Regarded as benign. Usually no specific follow-up beyond your routine care. |
| Bosniak IIF | More partitions, minimally thickened walls, or thicker calcification — still without clear enhancement. | Indeterminate. Followed with repeat imaging at intervals; stability over time is reassuring. |
| Bosniak III | Thickened or irregular walls or partitions that clearly take up contrast. | Treated as a lesion that needs a decision. Discussed at a tumour board; biopsy or surgical opinion. |
| Bosniak IV | A distinctly solid, enhancing component alongside the cystic part. | Managed as a kidney cancer until proven otherwise, with specialist uro-oncology referral. |
| Multiple small cysts, shrunken kidneys | The typical appearance of acquired cystic kidney disease after long-standing kidney failure. | An expected finding, not a diagnosis of cancer. Each individual cyst is judged on its own features. |
Categories are assigned on a good-quality scan and can move up or down when imaging is repeated or reviewed. Growth or new enhancement over time carries more weight than the label on any single report.
People living with kidney failure already spend a great deal of time in hospital, and a line in a scan report about “multiple cysts” is easy to leave unexplained in a busy dialysis unit. It rarely takes long to answer properly. Most of the time the answer is that the appearance is expected, nothing needs doing, and you can stop turning it over.
Your first consultation at CION is free and runs to about 45 minutes. Diagnosis is delivered in-house: bloods, ultrasound, CT, MRI and a biopsy where one is needed, across 35+ centres in Telangana and Andhra Pradesh — and the imaging plan is made in step with your nephrologist rather than in parallel with them. Genetic counselling, active-surveillance monitoring and survivorship care are in-house too. Where the answer sits outside oncology, we say so and point you back to your kidney team rather than keeping you in our clinic.
Where an assessment does find kidney cancer, CION delivers medical oncology and radiation in-house — immunotherapy and combination immunotherapy, targeted (TKI) and mTOR-class therapy, and SBRT. Kidney surgery of every kind, robotic surgery, ablation and PET-CT are coordinated with specialist urology, uro-oncology and interventional radiology partner centres and may be billed there. We say that upfront rather than leaving it to be discovered later, and it matters here: a small tumour in the only functioning kidney of someone with kidney disease is exactly the situation where which team does what needs to be clear from day one. What each option involves is set out on our kidney cancer treatment page.
Free and unhurried — long enough to read the report you already have, look at the images themselves, and explain what the wording means.
Contrast, scan choice and timing around dialysis are decided with your nephrologist, not around them. Nothing is ordered that your kidney doctor has not seen.
Any lesion that raises a question goes to a tumour board rather than being decided by one clinician working alone.
Decisions for healing, not billing. Scanning every person on dialysis every year answers nothing and worries everyone.
One consultation, a proper read of the images, and a plain answer on whether anything needs doing. Most people leave reassured and with a clear follow-up plan.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.Yes, the risk is higher than in people with healthy kidneys, and it tends to rise the longer someone has been on dialysis. It is still an uncommon event, and being on dialysis does not mean you are going to develop kidney cancer. The main reason for the increase is acquired cystic kidney disease: kidneys that have failed and shrunk gradually fill with small fluid-filled cysts, and a tumour occasionally arises from the lining of one of them. Tumours found this way are often small, are sometimes present in both kidneys, and are frequently picked up on a routine scan before they cause any symptom at all.
It is the development of multiple small cysts inside kidneys that have been damaged by long-standing kidney disease. Unlike the inherited condition, these cysts are not something you were born with and they are not passed on to your children. The kidneys usually stay small or shrink further rather than enlarging. It becomes more common the longer kidney failure has been present, and it can begin in advanced chronic kidney disease before dialysis ever starts. Most of these cysts are entirely harmless and simply sit there. A small number develop a solid area within them, and that is the change a scan is looking for.
Usually not. Up to a third of small kidney masses turn out to be benign, and simple, thin-walled cysts filled with clear fluid are among the commonest findings on any abdominal scan. What a radiologist looks at is not the presence of a cyst but its character: whether the wall is thickened, whether there are internal partitions, whether there is calcium within it, and above all whether any solid part takes up contrast. A cyst that is entirely simple needs nothing further. One with worrying features is either followed with repeat imaging or investigated. Change over time matters more than size at any single moment.
There is no blanket screening programme for everyone on dialysis, and scanning every patient routinely has not turned out to be the right answer for everybody. The decision is made individually with your kidney doctor, and it leans towards imaging when kidney failure has been present for many years, when someone started dialysis young and is expected to be on it for a long time, when a transplant is being planned, or when something has changed — pain, visible blood in the urine, or an unexpected shift in how anaemia is behaving. Where a scan is arranged, an ultrasound is usually the first look.
It changes it, but it does not remove it. In most people the original kidneys are left in place at transplant, so any cysts they contain remain and still need thinking about. A working transplant often causes acquired cysts to shrink over time, which helps. Against that, the medicines that stop the body rejecting a transplant reduce immune surveillance, and cancer risk in general is higher for people on long-term immunosuppression. In practice this means your transplant team keeps the native kidneys in view rather than forgetting about them, and a new symptom is looked into rather than assumed to be the transplant settling in.
Yes. Your first consultation is free, lasts about 45 minutes and needs no referral. Bloods, ultrasound, CT, MRI and a biopsy where one is needed are arranged in-house across 35+ CION centres in Telangana and Andhra Pradesh, and the choice of scan and whether contrast can be used is settled together with your kidney doctor. Where a scan turns out to be reassuring, we say so plainly. If kidney cancer is confirmed, CION's medical oncology and radiation teams deliver immunotherapy, targeted and mTOR-class therapy and SBRT directly, while kidney surgery, robotic surgery, ablation and PET-CT are coordinated with specialist partner centres and may be billed there.